AU4361699A - Novel angiotensin receptor, production and use thereof - Google Patents

Novel angiotensin receptor, production and use thereof Download PDF

Info

Publication number
AU4361699A
AU4361699A AU43616/99A AU4361699A AU4361699A AU 4361699 A AU4361699 A AU 4361699A AU 43616/99 A AU43616/99 A AU 43616/99A AU 4361699 A AU4361699 A AU 4361699A AU 4361699 A AU4361699 A AU 4361699A
Authority
AU
Australia
Prior art keywords
seq
sequence
ser
angiotensin
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43616/99A
Other languages
English (en)
Inventor
Holger Heitsch
Jorg-Peter Kleim
Gunther Riess
Gertrud Sibenhorn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Publication of AU4361699A publication Critical patent/AU4361699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU43616/99A 1998-06-08 1999-05-12 Novel angiotensin receptor, production and use thereof Abandoned AU4361699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19825494 1998-06-08
DE19825494A DE19825494A1 (de) 1998-06-08 1998-06-08 Neuer Angiotensin Rezeptor, Herstellung und Verwendung desselben
PCT/EP1999/003249 WO1999064585A2 (de) 1998-06-08 1999-05-12 Neuer angiotensin rezeptor, herstellung und verwendung desselben

Publications (1)

Publication Number Publication Date
AU4361699A true AU4361699A (en) 1999-12-30

Family

ID=7870244

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43616/99A Abandoned AU4361699A (en) 1998-06-08 1999-05-12 Novel angiotensin receptor, production and use thereof

Country Status (14)

Country Link
EP (1) EP1086217A2 (ko)
JP (1) JP2002517237A (ko)
KR (1) KR20010052703A (ko)
CN (1) CN1304449A (ko)
AR (1) AR020086A1 (ko)
AU (1) AU4361699A (ko)
BR (1) BR9912183A (ko)
CA (1) CA2330229A1 (ko)
DE (1) DE19825494A1 (ko)
HU (1) HUP0102540A3 (ko)
ID (1) ID27566A (ko)
PL (1) PL345949A1 (ko)
TR (1) TR200003662T2 (ko)
WO (1) WO1999064585A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1802361B1 (en) * 2004-10-21 2009-11-18 Medtronic, Inc. Angiotensin-(1-7) eluting polymer-coated medical device to reduce restenosis and improve endothelial cell function

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0647239A4 (en) * 1992-06-24 1997-07-02 Univ Washington ANGIOTENSIN IV PEPTIDES, AND RECEPTOR.

Also Published As

Publication number Publication date
BR9912183A (pt) 2001-04-10
CA2330229A1 (en) 1999-12-16
HUP0102540A3 (en) 2003-09-29
PL345949A1 (en) 2002-01-14
WO1999064585A2 (de) 1999-12-16
TR200003662T2 (tr) 2001-07-23
ID27566A (id) 2001-04-12
KR20010052703A (ko) 2001-06-25
DE19825494A1 (de) 1999-12-09
AR020086A1 (es) 2002-04-10
JP2002517237A (ja) 2002-06-18
CN1304449A (zh) 2001-07-18
HUP0102540A2 (hu) 2001-10-28
WO1999064585A3 (de) 2000-04-06
EP1086217A2 (de) 2001-03-28

Similar Documents

Publication Publication Date Title
Schüddekopf et al. The whn transcription factor encoded by the nude locus contains an evolutionarily conserved and functionally indispensable activation domain.
WO1994000469A1 (en) Novel tyrosine kinase
WO1994000469A9 (en) Novel tyrosine kinase
EP1012292A1 (en) Ntn-2 member of tnf ligand family
WO1998055621A1 (en) Ntn-2 member of tnf ligand family
WO1996002645A2 (en) Htk ligand
CA2299619A1 (en) Human orphan receptor ntr-1
US5614609A (en) Serine threonine kinase receptor
JP3989536B2 (ja) ガラニンレセプター、核酸、形質転換細胞、およびそれらの使用
AU4361699A (en) Novel angiotensin receptor, production and use thereof
AU748167B2 (en) Novel nucleic acid and polypeptide
EP1105477A1 (en) Dcr5, a bmp-binding protein, and applications thereof
EP0832117A1 (en) Ligand-stimulated gene expression
Lim et al. Characterization of the murine gene of gC1qBP, a novel cell protein that binds the globular heads of C1q, vitronectin, high molecular weight kininogen and factor XII
MXPA00012127A (en) Novel angiotensin receptor, production and use thereof
AU753400C (en) Orphan receptors
WO1997030156A2 (en) NUCLEOTIDES AND PEPTIDES CORRESPONDING TO THE CANINE IgE HEAVY CHAIN CONSTANT REGION AND RELATED METHODS
AU764484B2 (en) Orphan cytokine receptor
CZ20004545A3 (cs) Nový receptor angiotensinu, způsob jeho přípravy a jeho použití

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted